Continuous glucose monitoring (CGM) is a method used to monitor blood glucose levels continuously throughout the day and night. CGM systems consist of a sensor placed under the skin, which measures glucose levels and transmits data to a receiver or smartphone.
The global market for Continuos Glucose Monitoring was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
The market for continuous glucose monitoring is driven by the increasing adoption of CGM systems for improved diabetes management, especially in individuals with type 1 diabetes and insulin-dependent type 2 diabetes. Technological advancements in CGM sensors, such as improved accuracy and longer wear time, have also contributed to the market's growth.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Continuos Glucose Monitoring, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Continuos Glucose Monitoring by region & country, by Type, and by Application.
The Continuos Glucose Monitoring market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Continuos Glucose Monitoring.
Market Segmentation
By Company
Roche
LifeScan
Abbott
Ascensia
ARKRAY
I-SENS
Omron
B. Braun
77 Elektronika
AgaMatrix
ALL Medicus
Terumo
Yicheng
Acon
Medtrum Technologies
MicroTech Medical, Inc
Sinocare
Hybio Pharmaceutical
Lepu Medical
Yuyue Medical
Segment by Type:
Retrospective CGM (r-CGM)
Real-time continuous glucose monitoring (RT-CGM)
Segment by Application
Hospitals
Clinics
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Continuos Glucose Monitoring manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Continuos Glucose Monitoring in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Continuos Glucose Monitoring in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Market Overview
1.1 Continuos Glucose Monitoring Product Introduction
1.2 Global Continuos Glucose Monitoring Market Size Forecast
1.2.1 Global Continuos Glucose Monitoring Sales Value (2019-2030)
1.2.2 Global Continuos Glucose Monitoring Sales Volume (2019-2030)
1.2.3 Global Continuos Glucose Monitoring Sales Price (2019-2030)
1.3 Continuos Glucose Monitoring Market Trends & Drivers
1.3.1 Continuos Glucose Monitoring Industry Trends
1.3.2 Continuos Glucose Monitoring Market Drivers & Opportunity
1.3.3 Continuos Glucose Monitoring Market Challenges
1.3.4 Continuos Glucose Monitoring Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Continuos Glucose Monitoring Players Revenue Ranking (2023)
2.2 Global Continuos Glucose Monitoring Revenue by Company (2019-2024)
2.3 Global Continuos Glucose Monitoring Players Sales Volume Ranking (2023)
2.4 Global Continuos Glucose Monitoring Sales Volume by Company Players (2019-2024)
2.5 Global Continuos Glucose Monitoring Average Price by Company (2019-2024)
2.6 Key Manufacturers Continuos Glucose Monitoring Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Continuos Glucose Monitoring Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Continuos Glucose Monitoring
2.9 Continuos Glucose Monitoring Market Competitive Analysis
2.9.1 Continuos Glucose Monitoring Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Continuos Glucose Monitoring Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Continuos Glucose Monitoring as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Retrospective CGM (r-CGM)
3.1.2 Real-time continuous glucose monitoring (RT-CGM)
3.2 Global Continuos Glucose Monitoring Sales Value by Type
3.2.1 Global Continuos Glucose Monitoring Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Continuos Glucose Monitoring Sales Value, by Type (2019-2030)
3.2.3 Global Continuos Glucose Monitoring Sales Value, by Type (%) (2019-2030)
3.3 Global Continuos Glucose Monitoring Sales Volume by Type
3.3.1 Global Continuos Glucose Monitoring Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Continuos Glucose Monitoring Sales Volume, by Type (2019-2030)
3.3.3 Global Continuos Glucose Monitoring Sales Volume, by Type (%) (2019-2030)
3.4 Global Continuos Glucose Monitoring Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospitals
4.1.2 Clinics
4.1.3 Others
4.2 Global Continuos Glucose Monitoring Sales Value by Application
4.2.1 Global Continuos Glucose Monitoring Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Continuos Glucose Monitoring Sales Value, by Application (2019-2030)
4.2.3 Global Continuos Glucose Monitoring Sales Value, by Application (%) (2019-2030)
4.3 Global Continuos Glucose Monitoring Sales Volume by Application
4.3.1 Global Continuos Glucose Monitoring Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Continuos Glucose Monitoring Sales Volume, by Application (2019-2030)
4.3.3 Global Continuos Glucose Monitoring Sales Volume, by Application (%) (2019-2030)
4.4 Global Continuos Glucose Monitoring Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Continuos Glucose Monitoring Sales Value by Region
5.1.1 Global Continuos Glucose Monitoring Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Continuos Glucose Monitoring Sales Value by Region (2019-2024)
5.1.3 Global Continuos Glucose Monitoring Sales Value by Region (2025-2030)
5.1.4 Global Continuos Glucose Monitoring Sales Value by Region (%), (2019-2030)
5.2 Global Continuos Glucose Monitoring Sales Volume by Region
5.2.1 Global Continuos Glucose Monitoring Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Continuos Glucose Monitoring Sales Volume by Region (2019-2024)
5.2.3 Global Continuos Glucose Monitoring Sales Volume by Region (2025-2030)
5.2.4 Global Continuos Glucose Monitoring Sales Volume by Region (%), (2019-2030)
5.3 Global Continuos Glucose Monitoring Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Continuos Glucose Monitoring Sales Value, 2019-2030
5.4.2 North America Continuos Glucose Monitoring Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Continuos Glucose Monitoring Sales Value, 2019-2030
5.5.2 Europe Continuos Glucose Monitoring Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Continuos Glucose Monitoring Sales Value, 2019-2030
5.6.2 Asia Pacific Continuos Glucose Monitoring Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Continuos Glucose Monitoring Sales Value, 2019-2030
5.7.2 South America Continuos Glucose Monitoring Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Continuos Glucose Monitoring Sales Value, 2019-2030
5.8.2 Middle East & Africa Continuos Glucose Monitoring Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Continuos Glucose Monitoring Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Continuos Glucose Monitoring Sales Value
6.2.1 Key Countries/Regions Continuos Glucose Monitoring Sales Value, 2019-2030
6.2.2 Key Countries/Regions Continuos Glucose Monitoring Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Continuos Glucose Monitoring Sales Value, 2019-2030
6.3.2 United States Continuos Glucose Monitoring Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Continuos Glucose Monitoring Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Continuos Glucose Monitoring Sales Value, 2019-2030
6.4.2 Europe Continuos Glucose Monitoring Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Continuos Glucose Monitoring Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Continuos Glucose Monitoring Sales Value, 2019-2030
6.5.2 China Continuos Glucose Monitoring Sales Value by Type (%), 2023 VS 2030
6.5.3 China Continuos Glucose Monitoring Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Continuos Glucose Monitoring Sales Value, 2019-2030
6.6.2 Japan Continuos Glucose Monitoring Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Continuos Glucose Monitoring Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Continuos Glucose Monitoring Sales Value, 2019-2030
6.7.2 South Korea Continuos Glucose Monitoring Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Continuos Glucose Monitoring Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Continuos Glucose Monitoring Sales Value, 2019-2030
6.8.2 Southeast Asia Continuos Glucose Monitoring Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Continuos Glucose Monitoring Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Continuos Glucose Monitoring Sales Value, 2019-2030
6.9.2 India Continuos Glucose Monitoring Sales Value by Type (%), 2023 VS 2030
6.9.3 India Continuos Glucose Monitoring Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Roche
7.1.1 Roche Company Information
7.1.2 Roche Introduction and Business Overview
7.1.3 Roche Continuos Glucose Monitoring Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Roche Continuos Glucose Monitoring Product Offerings
7.1.5 Roche Recent Development
7.2 LifeScan
7.2.1 LifeScan Company Information
7.2.2 LifeScan Introduction and Business Overview
7.2.3 LifeScan Continuos Glucose Monitoring Sales, Revenue and Gross Margin (2019-2024)
7.2.4 LifeScan Continuos Glucose Monitoring Product Offerings
7.2.5 LifeScan Recent Development
7.3 Abbott
7.3.1 Abbott Company Information
7.3.2 Abbott Introduction and Business Overview
7.3.3 Abbott Continuos Glucose Monitoring Sales, Revenue and Gross Margin (2019-2024)
7.3.4 Abbott Continuos Glucose Monitoring Product Offerings
7.3.5 Abbott Recent Development
7.4 Ascensia
7.4.1 Ascensia Company Information
7.4.2 Ascensia Introduction and Business Overview
7.4.3 Ascensia Continuos Glucose Monitoring Sales, Revenue and Gross Margin (2019-2024)
7.4.4 Ascensia Continuos Glucose Monitoring Product Offerings
7.4.5 Ascensia Recent Development
7.5 ARKRAY
7.5.1 ARKRAY Company Information
7.5.2 ARKRAY Introduction and Business Overview
7.5.3 ARKRAY Continuos Glucose Monitoring Sales, Revenue and Gross Margin (2019-2024)
7.5.4 ARKRAY Continuos Glucose Monitoring Product Offerings
7.5.5 ARKRAY Recent Development
7.6 I-SENS
7.6.1 I-SENS Company Information
7.6.2 I-SENS Introduction and Business Overview
7.6.3 I-SENS Continuos Glucose Monitoring Sales, Revenue and Gross Margin (2019-2024)
7.6.4 I-SENS Continuos Glucose Monitoring Product Offerings
7.6.5 I-SENS Recent Development
7.7 Omron
7.7.1 Omron Company Information
7.7.2 Omron Introduction and Business Overview
7.7.3 Omron Continuos Glucose Monitoring Sales, Revenue and Gross Margin (2019-2024)
7.7.4 Omron Continuos Glucose Monitoring Product Offerings
7.7.5 Omron Recent Development
7.8 B. Braun
7.8.1 B. Braun Company Information
7.8.2 B. Braun Introduction and Business Overview
7.8.3 B. Braun Continuos Glucose Monitoring Sales, Revenue and Gross Margin (2019-2024)
7.8.4 B. Braun Continuos Glucose Monitoring Product Offerings
7.8.5 B. Braun Recent Development
7.9 77 Elektronika
7.9.1 77 Elektronika Company Information
7.9.2 77 Elektronika Introduction and Business Overview
7.9.3 77 Elektronika Continuos Glucose Monitoring Sales, Revenue and Gross Margin (2019-2024)
7.9.4 77 Elektronika Continuos Glucose Monitoring Product Offerings
7.9.5 77 Elektronika Recent Development
7.10 AgaMatrix
7.10.1 AgaMatrix Company Information
7.10.2 AgaMatrix Introduction and Business Overview
7.10.3 AgaMatrix Continuos Glucose Monitoring Sales, Revenue and Gross Margin (2019-2024)
7.10.4 AgaMatrix Continuos Glucose Monitoring Product Offerings
7.10.5 AgaMatrix Recent Development
7.11 ALL Medicus
7.11.1 ALL Medicus Company Information
7.11.2 ALL Medicus Introduction and Business Overview
7.11.3 ALL Medicus Continuos Glucose Monitoring Sales, Revenue and Gross Margin (2019-2024)
7.11.4 ALL Medicus Continuos Glucose Monitoring Product Offerings
7.11.5 ALL Medicus Recent Development
7.12 Terumo
7.12.1 Terumo Company Information
7.12.2 Terumo Introduction and Business Overview
7.12.3 Terumo Continuos Glucose Monitoring Sales, Revenue and Gross Margin (2019-2024)
7.12.4 Terumo Continuos Glucose Monitoring Product Offerings
7.12.5 Terumo Recent Development
7.13 Yicheng
7.13.1 Yicheng Company Information
7.13.2 Yicheng Introduction and Business Overview
7.13.3 Yicheng Continuos Glucose Monitoring Sales, Revenue and Gross Margin (2019-2024)
7.13.4 Yicheng Continuos Glucose Monitoring Product Offerings
7.13.5 Yicheng Recent Development
7.14 Acon
7.14.1 Acon Company Information
7.14.2 Acon Introduction and Business Overview
7.14.3 Acon Continuos Glucose Monitoring Sales, Revenue and Gross Margin (2019-2024)
7.14.4 Acon Continuos Glucose Monitoring Product Offerings
7.14.5 Acon Recent Development
7.15 Medtrum Technologies
7.15.1 Medtrum Technologies Company Information
7.15.2 Medtrum Technologies Introduction and Business Overview
7.15.3 Medtrum Technologies Continuos Glucose Monitoring Sales, Revenue and Gross Margin (2019-2024)
7.15.4 Medtrum Technologies Continuos Glucose Monitoring Product Offerings
7.15.5 Medtrum Technologies Recent Development
7.16 MicroTech Medical, Inc
7.16.1 MicroTech Medical, Inc Company Information
7.16.2 MicroTech Medical, Inc Introduction and Business Overview
7.16.3 MicroTech Medical, Inc Continuos Glucose Monitoring Sales, Revenue and Gross Margin (2019-2024)
7.16.4 MicroTech Medical, Inc Continuos Glucose Monitoring Product Offerings
7.16.5 MicroTech Medical, Inc Recent Development
7.17 Sinocare
7.17.1 Sinocare Company Information
7.17.2 Sinocare Introduction and Business Overview
7.17.3 Sinocare Continuos Glucose Monitoring Sales, Revenue and Gross Margin (2019-2024)
7.17.4 Sinocare Continuos Glucose Monitoring Product Offerings
7.17.5 Sinocare Recent Development
7.18 Hybio Pharmaceutical
7.18.1 Hybio Pharmaceutical Company Information
7.18.2 Hybio Pharmaceutical Introduction and Business Overview
7.18.3 Hybio Pharmaceutical Continuos Glucose Monitoring Sales, Revenue and Gross Margin (2019-2024)
7.18.4 Hybio Pharmaceutical Continuos Glucose Monitoring Product Offerings
7.18.5 Hybio Pharmaceutical Recent Development
7.19 Lepu Medical
7.19.1 Lepu Medical Company Information
7.19.2 Lepu Medical Introduction and Business Overview
7.19.3 Lepu Medical Continuos Glucose Monitoring Sales, Revenue and Gross Margin (2019-2024)
7.19.4 Lepu Medical Continuos Glucose Monitoring Product Offerings
7.19.5 Lepu Medical Recent Development
7.20 Yuyue Medical
7.20.1 Yuyue Medical Company Information
7.20.2 Yuyue Medical Introduction and Business Overview
7.20.3 Yuyue Medical Continuos Glucose Monitoring Sales, Revenue and Gross Margin (2019-2024)
7.20.4 Yuyue Medical Continuos Glucose Monitoring Product Offerings
7.20.5 Yuyue Medical Recent Development
8 Industry Chain Analysis
8.1 Continuos Glucose Monitoring Industrial Chain
8.2 Continuos Glucose Monitoring Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Continuos Glucose Monitoring Sales Model
8.5.2 Sales Channel
8.5.3 Continuos Glucose Monitoring Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
Roche
LifeScan
Abbott
Ascensia
ARKRAY
I-SENS
Omron
B. Braun
77 Elektronika
AgaMatrix
ALL Medicus
Terumo
Yicheng
Acon
Medtrum Technologies
MicroTech Medical, Inc
Sinocare
Hybio Pharmaceutical
Lepu Medical
Yuyue Medical
听
听
*If Applicable.
